Literature DB >> 25510937

Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.

Michael Loureiro1, Justine Renard1, Jordan Zunder1, Steven R Laviolette2.   

Abstract

Disturbances in cannabinoid type 1 receptor (CB1R) signaling have been linked to emotional and cognitive deficits characterizing neuropsychiatric disorders, including schizophrenia. Thus, there is growing interest in characterizing the relationship between cannabinoid transmission, emotional processing, and dopamine (DA)-dependent behavioral deficits. The CB1R is highly expressed in the mammalian nervous system, particularly in the hippocampus. Activation of the ventral hippocampal subregion (vHipp) is known to increase both the activity of DAergic neurons located in the ventral tegmental area (VTA) and DA levels in reward-related brain regions, particularly the nucleus accumbens (NAc). However, the possible functional relationship between hippocampal CB1R transmission and VTA DA neuronal activity is not currently understood. In this study, using in vivo neuronal recordings in rats, we demonstrate that activation of CB1R in the vHipp strongly increases VTA DA neuronal firing and bursting activity, while simultaneously decreasing the activity of VTA non-DA neurons. Furthermore, using a conditioned place preference procedure and a social interaction test, we report that intra-vHipp CB1R activation potentiates the reward salience of normally sub-threshold conditioning doses of opiates and induces deficits in natural sociability and social recognition behaviors. Finally, these behavioral effects were prevented by directly blocking NAc DAergic transmission. Collectively, these findings identify hippocampal CB1R transmission as a critical modulator of the mesolimbic DA pathway and in the processing of reward and social-related behavioral phenomena.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25510937      PMCID: PMC4397402          DOI: 10.1038/npp.2014.329

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

1.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.

Authors:  G Marsicano; B Lutz
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

Review 2.  A brain on cannabinoids: the role of dopamine release in reward seeking.

Authors:  Erik B Oleson; Joseph F Cheer
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

3.  In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder.

Authors:  Unn K Haukvik; Lars T Westlye; Lynn Mørch-Johnsen; Kjetil N Jørgensen; Elisabeth H Lange; Anders M Dale; Ingrid Melle; Ole A Andreassen; Ingrid Agartz
Journal:  Biol Psychiatry       Date:  2014-07-03       Impact factor: 13.382

Review 4.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

5.  Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.

Authors:  S B Floresco; C L Todd; A A Grace
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

6.  Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.

Authors:  Miriam Melis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Beat Lutz; Giovanni Marsicano; Vincenzo Di Marzo; Gian Luigi Gessa; Marco Pistis
Journal:  J Neurosci       Date:  2004-11-24       Impact factor: 6.167

7.  GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.

Authors:  I Katona; B Sperlágh; Z Maglóczky; E Sántha; A Köfalvi; S Czirják; K Mackie; E S Vizi; T F Freund
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 8.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

Review 9.  Neural circuits subserving behavioral flexibility and their relevance to schizophrenia.

Authors:  Stan B Floresco; Ying Zhang; Takeshi Enomoto
Journal:  Behav Brain Res       Date:  2008-12-06       Impact factor: 3.332

Review 10.  Dopaminergic control of cognitive flexibility in humans and animals.

Authors:  Marianne Klanker; Matthijs Feenstra; Damiaan Denys
Journal:  Front Neurosci       Date:  2013-11-05       Impact factor: 4.677

View more
  21 in total

Review 1.  WHY NOT POT?: A Review of the Brain-based Risks of Cannabis.

Authors:  Kai MacDonald; Katherine Pappas
Journal:  Innov Clin Neurosci       Date:  2016-04-01

Review 2.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

3.  Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.

Authors:  Hanna J Szkudlarek; Sagar J Desai; Justine Renard; Brian Pereira; Christopher Norris; Christina E L Jobson; Nagalingam Rajakumar; Brian L Allman; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

Review 4.  The neurobiology of social play and its rewarding value in rats.

Authors:  Louk J M J Vanderschuren; E J Marijke Achterberg; Viviana Trezza
Journal:  Neurosci Biobehav Rev       Date:  2016-08-29       Impact factor: 8.989

5.  Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.

Authors:  Roger Hudson; Justine Renard; Christopher Norris; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2019-09-30       Impact factor: 6.167

6.  Dopaminergic Neurotransmission in the Nucleus Accumbens Modulates Social Play Behavior in Rats.

Authors:  Antonia Manduca; Michela Servadio; Ruth Damsteegt; Patrizia Campolongo; Louk Jmj Vanderschuren; Viviana Trezza
Journal:  Neuropsychopharmacology       Date:  2016-02-10       Impact factor: 7.853

Review 7.  Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology.

Authors:  Roger Hudson; Walter Rushlow; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-10-24       Impact factor: 4.530

8.  Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Δ9-Tetrahydrocannabinol Exposure.

Authors:  Eun-Kyung Hwang; Carl R Lupica
Journal:  Biol Psychiatry       Date:  2019-08-06       Impact factor: 13.382

9.  Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.

Authors:  Justine Renard; Michael Loureiro; Laura G Rosen; Jordan Zunder; Cleusa de Oliveira; Susanne Schmid; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

10.  Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System.

Authors:  Christopher Norris; Michael Loureiro; Cecilia Kramar; Jordan Zunder; Justine Renard; Walter Rushlow; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2016-06-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.